Navellier & Associates’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-173,391
Closed -$7.6M 334
2025
Q4
$7.6M Buy
173,391
+1,077
+0.6% +$44.6K 0.85% 27
2025
Q3
$7.12M Sell
172,314
-19,247
-10% -$774K 0.72% 32
2025
Q2
$8.44M Buy
191,561
+46,503
+32% +$1.86M 1.05% 20
2025
Q1
$5.78M Buy
145,058
+113,879
+365% +$4.06M 0.8% 33
2024
Q4
$1.04M Buy
31,179
+9,109
+41% +$296K 0.12% 155
2024
Q3
$573K Buy
+22,070
New +$549K 0.08% 198
2018
Q1
Sell
-74,942
Closed -$2.28M 315
2017
Q4
$2.28M Buy
74,942
+19,394
+35% +$516K 0.43% 83
2017
Q3
$1.35M Buy
55,548
+12,737
+30% +$339K 0.26% 83
2017
Q2
$1.05M Buy
+42,811
New +$906K 0.16% 138

Other funds holding EXEL

Navellier & Associates's EXEL Position: Q1 2026 in Review

Navellier & Associates sold out of Exelixis (EXEL) in Q1 2026, closing a stake of 173,391 shares — an estimated $7.6M sold.

Navellier & Associates first reported a position in EXEL in Q2 2017 and held it in 9 quarters. The position peaked at $8.44M in Q2 2025. 695 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • Navellier & Associates reported no remaining Exelixis position as of Q1 2026 after selling out during the quarter.
  • Navellier & Associates sold 173,391 Exelixis shares in Q1 2026, an estimated $7.6M.
  • Navellier & Associates first reported a position in Exelixis in Q2 2017 and held it in 9 quarters.
  • Navellier & Associates's Exelixis position peaked at $8.44M in Q2 2025.
  • 695 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Navellier & Associates's 13F filing for Q1 2026, filed 7 May 2026.